Abstract
Elevated levels of Lipid Metabolism-related Inflammatory Indices (LMIIs)—specifically NHR, MHR, PHR, and LHR—are significantly associated with an increased risk of incident peripheral artery disease (PAD) among elderly patients with Type 2 Diabetes Mellitus (T2DM). This multicohort study, involving over 16,000 participants from China and the UK, identifies kidney function (eGFR) as a key biological mediator. The associations are particularly pronounced in females and individuals with poor glycemic control, suggesting that these low-cost biomarkers could enhance personalized risk assessment and prevention strategies.
Introduction: The Challenge of Asymptomatic PAD
Peripheral artery disease (PAD) is a debilitating complication of atherosclerosis that restricts blood flow to the limbs. Patients with Type 2 Diabetes Mellitus (T2DM) face a two- to four-fold higher risk of developing PAD compared to the general population. A critical challenge in clinical practice is that early-stage PAD in diabetic patients is often asymptomatic due to concurrent neuropathy, making early detection vital to prevent severe outcomes like chronic pain or amputation.
Atherosclerosis is fundamentally driven by the interplay between systemic inflammation and lipid dysregulation. While individual markers exist, composite biomarkers known as LMIIs—ratios of immune cells (neutrophils, monocytes, platelets, and lymphocytes) to high-density lipoprotein cholesterol (HDL-C)—offer a more integrated view of vascular health. This study rigorously evaluates the longitudinal relationship between baseline LMIIs and the onset of PAD.
Study Participants and Objectives
The research utilizes two large, distinct datasets to ensure the generalizability of its findings: the Jinshan Cohort from China and the UK Biobank.
- The Jinshan Cohort (China): 2,837 participants aged $\ge$ 60 with T2DM, followed for approximately 2 years.
- The UK Biobank (UK): 13,542 participants aged $\ge$ 60 with T2DM, followed for a median of 13.16 years.
The primary objective was to evaluate the associations between four specific LMIIs (NHR, MHR, PHR, LHR) and the risk of incident PAD across these diverse populations.
Methodological Approach: Ensuring Causal Rigor
To move beyond simple correlation, the researchers employed a sophisticated analytical framework designed to control for both measured and unmeasured confounding variables.
The methodology included:
- Standard Modeling: Logistic regression and Cox proportional-hazards models were used for the Chinese and UK cohorts, respectively.
- Generalized Propensity Score (GPS): This technique balanced measured confounders across continuous exposure levels, mimicking a randomized controlled trial environment.
- Negative Control Exposure (NCE): By testing variables with no known causal link to PAD, the researchers calibrated their models to detect and adjust for residual bias.
- Causal Mediation Analysis: Using VanderWeele’s method, the team explored whether liver or kidney function indicators acted as biological intermediaries in the pathway from inflammation to PAD.
Key Insights and Results
The study yielded several critical findings regarding the predictive power of LMIIs:
1. Consistent Risk Elevation
All four LMIIs were positively and significantly associated with incident PAD in both cohorts. In the Jinshan Cohort, a one-unit increase in the platelet-to-HDL ratio (PHR) was associated with a 69% increase in the odds of developing PAD (OR = 1.69). In the UK Biobank, hazard ratios remained significant over the long term, with PHR showing a hazard ratio (HR) of 1.19.
2. The Role of Kidney Function
A major discovery was that the estimated glomerular filtration rate (eGFR) mediates the relationship between inflammatory indices and PAD. High systemic inflammation appears to impair kidney function, which subsequently accelerates the progression of arterial disease. eGFR accounted for approximately 10% to 21% of the total effect across both cohorts.
3. Population Heterogeneity
The impact of LMIIs was not uniform across all subgroups. Stronger associations were observed in:
- Females: Potentially due to hormonal influences on inflammation and lipid metabolism.
- Poor Glycemic Control: Patients with HbA1c $\ge$ 7% showed higher vulnerability.
- Smokers: Smoking appeared to exacerbate the inflammatory risk.
- Aspirin Use: In the UK cohort, aspirin appeared to mitigate some of the risk associated with high LMIIs, highlighting its anti-inflammatory benefits.
Conclusion and Future Directions
This study provides robust evidence that LMIIs are effective, low-cost biomarkers for predicting PAD risk in elderly diabetic patients. By integrating lipid and inflammatory data, these indices offer a holistic view of a patient's vascular risk profile.
While the study is limited by single-point baseline measurements and potential "healthy volunteer bias" in the UK Biobank, it sets the stage for future research. Longitudinal studies tracking dynamic changes in LMIIs and deeper biological investigations into the inflammation-kidney-vasculature axis will be essential for developing targeted, personalized preventive strategies for PAD.
Summary updated